Name Funds holding
in top 10
Growth Growth % Return since
31 Mar ‘17
126
2 +1 +100% 15.6%
127
2 +1 +100% 34.5%
128
2 +1 +100% 213%
FATE icon
129
Fate Therapeutics
FATE
$331M
2 +1 +100% 37.6%
130
2 +1 +100% 495%
131
2 +1 +100% 77.4%
132
2 +1 +100% 192%
133
2 +1 +100% 50.7%
134
2 +1 +100% 57.4%
135
2 +1 +100% 12.2%
RARE icon
136
Ultragenyx Pharmaceutical
RARE
$2.36B
2 +1 +100% 64.7%
137
2 +1 +100% 60%
138
2 +1 +100% 832%
139
2 +1 +100% 5.62%
140
2 +1 +100% 211%
141
2 +1 +100% 21.9%
142
2 +1 +100% 60%
143
2 +1 +100% 14.8%
144
2 +1 +100% 19.1%
145
2 +1 +100% 22.7%
146
2 +1 +100% 87.1%
147
2 +1 +100% 444%
148
2 +1 +100% 449%
149
2 +1 +100% 67.1%
150
2 +1 +100% 68.3%